$PMCB ~ The "Financial Times”, the world’s leading global business publication, published that PharmaCyte has completed the preparation of the Master Cell Bank of the cells destined to be part of the treatment for pancreatic cancer and the cells will now enter the testing phase. Both of these activities were performed by Eurofins as a subcontractor. Austrianova will receive the cells, once testing is complete, and commence the manufacture of the the encapsulated cell clinical trial product. https://markets.ft.com/data/announce/detail?d...__BW5609-1